Most Read Articles
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 2 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.

Therapeutic efficacy predictors of methylprednisolone in thyroid-associated ophthalmopathy

10 Oct 2018

The efficacy of intravenous methylprednisolone (IVMP) for treating moderate-to-severe active thyroid-associated ophthalmopathy (TAO) may be predicted by factors such as levels of thyroid stimulating hormone (TSH), anti-TSH-receptor antibodies (TRABs) and triglycerides, as well as eye symptom duration, a study reports.

Researchers looked at 302 consecutive patients with moderate-to-severe and active TAO who underwent the full IVMP therapy course. They identified independent predictors of treatment efficacy in the training set (n=200) and validated the prediction model in the validation set (n=102).

Multivariable logistic regression analysis revealed therapeutic efficacy to be associated with pretreatment clinical activity score (odds ratio [OR], 3.506; p<0.001), elevated TSH levels during treatment (OR, 0.145; p=0.005), pretreatment anti-TRAB levels (OR, 0.061; p<0.001), duration of eye symptoms (OR, 0.878; p=0.017) and pretreatment triglyceride levels (OR, 0.090; p=0.001).

The multivariable prediction model demonstrated good calibration and excellent discrimination, with an area under curve of 0.915 in the training set (p<0.001) and 0.885 (p<0.001) in the validation set.

Overall, the present data indicate that low pretreatment clinical activity score, positive pretreatment TRAB levels, prolonged duration of eye symptoms, elevated TSH levels during treatment, and high pretreatment triglyceride levels may negatively affect IVMP efficacy for moderate-to-severe TAO, according to researchers.

Additionally, the prediction model may help clinicians determine the indication and prognosis of IVMP therapy. In the management of TAO patients, researchers suggested early diagnosis and treatment (within 15 months), prompt restoration and maintenance of euthyroidism (meticulous control of TSH levels, ≤5 μIU/mL) and regular monitoring of triglyceride levels.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 2 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.